QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
- 16 June 2021Portfolio NewsVeranex Announces Investment From Summit Partners to Form Comprehensive Concept-to-Commercialization Medtech Services Company
- 12 June 2021SV NewsKate Bingham is recognised in this year's Queen’s Birthday Honours List
- 11 June 2021SV NewsRight or wrong, the aducanumab decision could turbo-boost investor interest in neurodegeneration
- 9 June 2021SV NewsThe Dementia Discovery Fund’s Portfolio Company Caraway Therapeutics Establishes Collaboration with AbbVie to develop small molecule therapeutics targeting Parkinson’s disease and other neurodegenerative disorders
- 9 June 2021Portfolio NewsCaraway Therapeutics Establishes Collaboration with AbbVie to Develop Novel Small Molecule Therapeutics for Parkinson’s Disease and Other Related Disorders
- 7 June 2021SV NewsThe Dementia Discovery Fund welcomes FDA’s approval of aducanumab for Alzheimer’s disease
- 2 June 2021Portfolio NewsTransine Therapeutics Closes Extended Seed Funding of £9.1 million co-led by Takeda Ventures, Inc. and the Dementia Discovery Fund to advance its novel class of therapeutic RNAs
- 27 May 2021Portfolio NewsPulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945
- 26 May 2021Portfolio NewsQurAlis Boosts World-Class Leadership Team With Addition of Three New Members
- Video19 May 2021SV News'In Conversation Live with Kate Bingham' Royal Society of Medicine
- 18 May 2021Portfolio NewsMestag Therapeutics announces collaboration with Janssen, focused on the discovery of novel fibroblast targets for the treatment of inflammatory disease
- 17 May 2021Portfolio NewsImbria Pharmaceuticals Presents Phase 1 and Preclinical Data of IMB-1018972 (IMB-101), an Investigational Cardiac Mitotrope , at the American College of Cardiology 70th Annual Scientific Session & Expo